| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/23/1992 | WO1992001059A1 Cdr grafted anti-cea antibodies and their production |
| 01/23/1992 | WO1992001057A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | WO1992001056A1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 01/23/1992 | WO1992001050A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | WO1992001047A1 Methods for producing members of specific binding pairs |
| 01/23/1992 | WO1992001044A1 Mouse/human heterohybrid cell line el41 and methods for the production of human monoclonal antibodies |
| 01/23/1992 | WO1992001000A1 Basophil granule proteins |
| 01/23/1992 | WO1992000997A1 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 01/23/1992 | WO1992000994A1 Growth-promoting agent |
| 01/23/1992 | WO1992000757A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2087008A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | CA2086932A1 Basophil granule proteins |
| 01/23/1992 | CA2086829A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2086739A1 Ehv-4 glycoprotein vaccine |
| 01/22/1992 | EP0467839A1 In vitro processing of fusion proteins |
| 01/22/1992 | EP0467782A1 Myocardial infarction immunoassay |
| 01/22/1992 | EP0467701A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467700A2 Coconjugate vaccines comprising immunogenic protein, HIV related peptides, and anionic moieties |
| 01/22/1992 | EP0467416A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/22/1992 | EP0467366A2 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents |
| 01/22/1992 | EP0466995A2 Sucrose phosphate synthase (SPS), its process for preparation, its cDNA, and utilization of cDNA to modify the expression of SPS in the plant cells |
| 01/22/1992 | EP0466854A1 T cell growth factor |
| 01/22/1992 | EP0466806A1 Phosphatidylinositol linking of proteins |
| 01/22/1992 | EP0466780A1 Megakaryocyte growth promoting activity |
| 01/22/1992 | EP0432218A4 Method for detecting cellular pathology |
| 01/21/1992 | WO1992001474A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | US5082931 Type II bacterial Fc receptors |
| 01/21/1992 | US5082928 Method of preparing conjugated antibodies |
| 01/21/1992 | US5082927 Genetic engineering, immunology |
| 01/21/1992 | US5082926 Polypeptide with type iv collagen cell adhesion, spreading and motility activity |
| 01/21/1992 | US5082657 Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
| 01/21/1992 | CA2087163A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | CA1294570C Monoclonal antibodies specifically directed against prosomal proteins |
| 01/20/1992 | WO1992001472A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | WO1992001464A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs |
| 01/20/1992 | CA2087541A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2087169A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs |
| 01/20/1992 | CA2047078A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047073A1 Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
| 01/20/1992 | CA2045231A1 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents |
| 01/19/1992 | WO1992001808A1 Reagent for diagnosing mycoplasma pneumoniae |
| 01/19/1992 | WO1992001719A1 Chimeric hiv-1-neutralizing immunoglobulins |
| 01/19/1992 | CA2087528A1 Chimeric hiv-1-neutralizing immunoglobulins |
| 01/19/1992 | CA2047298A1 Myocardial infarction immunoassay |
| 01/18/1992 | WO1992001781A1 Antibody-mediated cofactor-driven reactions |
| 01/18/1992 | CA2086755A1 Antibody-mediated cofactor-driven reactions |
| 01/17/1992 | WO1992001797A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
| 01/17/1992 | CA2084189A1 Immunoglobulin production by trichoderma |
| 01/17/1992 | CA2028526A1 Method for the purification of immunoreactive labeled thyroxine conjugates |
| 01/15/1992 | EP0466565A1 Kit for the specific determination of Angiotensin II |
| 01/15/1992 | EP0466505A2 Artificial antibody |
| 01/15/1992 | EP0466222A1 Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using |
| 01/15/1992 | EP0466199A1 Polypeptide fragments of factor VIIIc, corresponding probes and DNA sequences and DNA constructs |
| 01/15/1992 | EP0466174A1 Novel physiologically active porcine peptide (CNP-53) |
| 01/15/1992 | EP0465979A1 Anti HTLV-III (strain MN) monoclonal antibody |
| 01/15/1992 | EP0465652A1 Antibody against heavy chain of smooth muscle myosin |
| 01/15/1992 | EP0465633A1 C4 binding protein fusion proteins |
| 01/15/1992 | EP0465602A1 METHOD FOR DETECTION AND/OR IDENTIFICATION OF $i(LYSSAVIRUS) INFECTIONS, CLONING AND EXPRESSION OF GENES CODING FOR PEPTIDES AND/OR FRAGMENTS OF PEPTIDES OF MOKOLA $i(LYSSAVIRUS), VACCINE AGAINST THE MOKOLA VIRUS AND/OR THE FAMILY OF $i(LYSSAVIRUSES) AS WELL AS METHOD FOR OBTAINING SAID VACCINE VIA |
| 01/15/1992 | EP0465539A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 01/15/1992 | EP0367795A4 Affinity separating using immobilized flocculating reagents |
| 01/15/1992 | CN1057785A Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof |
| 01/14/1992 | US5081235 Chimeric anti-cea antibody |
| 01/14/1992 | US5081230 Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein |
| 01/14/1992 | US5081227 Germ cell alkaline phosphatase |
| 01/14/1992 | US5081034 Genetic engineering |
| 01/14/1992 | US5081032 Anti-human pulmonary adenocarcinoma monoclonal antibody |
| 01/14/1992 | US5081028 Preparation of transformed hosts which express binding factor related polypeptides |
| 01/14/1992 | US5081010 Alcoholamine, ethylene oxide alkylphenol compound; medical diagnosis |
| 01/14/1992 | US5080895 Specific antibody-containing substance from eggs and method of production and use thereof |
| 01/14/1992 | CA1294233C Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
| 01/14/1992 | CA1294218C Method and agents for inhibiting protein aging |
| 01/13/1992 | WO1992001051A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/13/1992 | CA2087005A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/12/1992 | WO1992000985A1 Streptomyces vectors for production of heterologous proteins |
| 01/12/1992 | WO1992000755A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 01/12/1992 | CA2087018A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 01/12/1992 | CA2087017A1 Streptomyces vectors for production of heterologous proteins |
| 01/11/1992 | WO1992001043A1 Hybridoma which produces avian specific immunoglobulin g |
| 01/11/1992 | CA2066433A1 Chicken-specific immunoglobulin g-producing hybridoma |
| 01/09/1992 | WO1992000387A1 Neurofibromatosis gene |
| 01/09/1992 | WO1992000383A1 Antibodies specific for the transglutaminase-induced isopeptide bond |
| 01/09/1992 | WO1992000378A1 Dna sequence for a serine protease and associated items |
| 01/09/1992 | WO1992000376A1 Mast cell growth factor |
| 01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000327A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 01/09/1992 | WO1992000326A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(b) |
| 01/09/1992 | WO1992000311A1 Probes for detecting mutant p53 |
| 01/09/1992 | WO1992000092A1 Ligand for cd28 receptor on b cells and methods |
| 01/09/1992 | WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/09/1992 | WO1992000083A1 Platelet fibrinogen-specific monoclonal antibody |
| 01/09/1992 | WO1992000055A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/09/1992 | WO1991007483A3 Mammalian pancreatic cholesterol esterase |
| 01/09/1992 | CA2086334A1 Neurofibromatosis gene |
| 01/09/1992 | CA2086091A1 Human macrophage inflammatory protein 2o |
| 01/09/1992 | CA2086088A1 Human macrophage inflammatory protein 2.beta. |
| 01/09/1992 | CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | CA2084413A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/09/1992 | CA2064555A1 Probes for detecting mutant p53 |
| 01/08/1992 | EP0465415A2 Monoclonal antibodies to mycosphaerella species |